Siew-Fei Ngu Hextan Y S Ngan Karen K L Chan
10.20517/cdr.2022.12
Cancer Drug Resist
2022 Jun 22;5(3):662-666.
brca ovarian cancer parp inhibitor rad51c
CC BY
https://pubmed.ncbi.nlm.nih.gov/36176748/
Case Reports
PMC9511802
36176748
A patient with relapsed high-grade serous ovarian carcinoma with somatic RAD51C mutations treated with PARPi monotherapy: a case report
2022